{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-035521","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.352376+00:00","generated_at":"2026-05-29T23:50:10.167862+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NRx Q3 net operating loss down 74% to $1.6M; on track for NDA filings by year-end","bullets":["Net operating loss $1.6M in Q3 2024 vs $6.1M in Q3 2023; nine-month net loss $16.1M vs $25.8M.","Cash $1.6M at Sep 30; closed $5.4M second tranche from Anson Funds post-quarter; $10.8M total convertible debt.","Expects to file NDAs for NRX-100 (IV ketamine) and NRX-101 (bipolar depression) by end of 2024, with 2025 PDUFA dates.","HOPE Therapeutics signed two non-binding LOIs to acquire Interventional Psychiatry Clinics; first revenue forecast by year-end 2024.","Retired Streeterville debt at substantial discount; litigation settled."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-035521","json":"https://secwatch.observer/filing/0001437749-24-035521.json","markdown":"https://secwatch.observer/filing/0001437749-24-035521.md","text":"https://secwatch.observer/filing/0001437749-24-035521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774924035521/0001437749-24-035521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774924035521/nrxp20241115_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:50:10.167862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}